289 related articles for article (PubMed ID: 32735324)
21. Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
Paik JS; Cho WK; Oh EH; Lee SB; Yang SW
Mol Vis; 2012; 18():1467-77. PubMed ID: 22736938
[TBL] [Abstract][Full Text] [Related]
22. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Effect of Protocatechuic Aldehyde in an In Vitro Model of Graves' Orbitopathy.
Byun JW; Hwang S; Kang CW; Kim JH; Chae MK; Yoon JS; Lee EJ
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4055-62. PubMed ID: 27494347
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
Park HY; Chae MK; Ko J; Kikkawa DO; Jang SY; Yoon JS
PLoS One; 2022; 17(12):e0279060. PubMed ID: 36521376
[TBL] [Abstract][Full Text] [Related]
25. Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.
Kim BY; Choi SH; Kim JY; Ko J; Yook JI; Kim HS; Lee EJ; Kikkawa DO; Yoon JS
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):7. PubMed ID: 35671049
[TBL] [Abstract][Full Text] [Related]
26. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
27. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
28. 4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy.
Yoon Y; Chae MK; Lee EJ; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1095-1102. PubMed ID: 31900640
[TBL] [Abstract][Full Text] [Related]
29. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
Jung SJ; Choi YJ; Park TK; Woo SE; Kim BY; Yoon JS; Jang SY
Br J Ophthalmol; 2022 Jul; 106(7):1019-1027. PubMed ID: 34193409
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.
Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC
Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648
[No Abstract] [Full Text] [Related]
31. Neferine suppresses autophagy-induced inflammation, oxidative stress and adipocyte differentiation in Graves' orbitopathy.
Li H; Gao L; Min J; Yang Y; Zhang R
J Cell Mol Med; 2021 Feb; 25(4):1949-1957. PubMed ID: 33443817
[TBL] [Abstract][Full Text] [Related]
32. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
Liu J; Farmer SR
J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
[TBL] [Abstract][Full Text] [Related]
33. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation.
Ohashi E; Kohno K; Arai N; Harashima A; Ariyasu T; Ushio S
Biol Pharm Bull; 2019; 42(6):968-976. PubMed ID: 31155593
[TBL] [Abstract][Full Text] [Related]
34. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS
J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093
[TBL] [Abstract][Full Text] [Related]
35. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Effect of Resveratrol on Oxidative Stress in Graves' Orbitopathy Orbital Fibroblasts.
Kim CY; Lee HJ; Chae MK; Byun JW; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6352-61. PubMed ID: 26436888
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy.
Görtz GE; Philipp S; Bruderek K; Jesenek C; Horstmann M; Henning Y; Oeverhaus M; Daser A; Bechrakis NE; Eckstein A; Brandau S; Berchner-Pfannschmidt U
Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36477465
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
[TBL] [Abstract][Full Text] [Related]
39. Autophagy is involved in the initiation and progression of Graves' orbitopathy.
Yoon JS; Lee HJ; Chae MK; Lee EJ
Thyroid; 2015 Apr; 25(4):445-54. PubMed ID: 25687157
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression.
Vines A; Cahoon S; Goldberg I; Saxena U; Pillarisetti S
J Biol Chem; 2006 Jun; 281(25):16985-16990. PubMed ID: 16601113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]